FDA Clears DDC Technique for K2M’s Mesa Platform

October 11, 2018

K2M’s dual differential correction (DDC) technique was granted 510(k) clearance by the FDA for use with the company’s Mesa Platform.

The platform is used for treating patients with sagittal imbalances, front-to-back imbalances in the spine that occur when one of the natural curves of the spine becomes under- or overly-pronounced.

The DDC technique uses patient-specific rods and rails, as well as rod rigidity and degree of bend, to correct spinal imbalances in the patient.

View today's stories